Literature DB >> 7866921

Localization of follistatin, an activin-binding protein, in bone tissues.

S Inoue1, S Nomura, T Hosoi, Y Ouchi, H Orimo, M Muramatsu.   

Abstract

We have previously reported that activin-A has a mitogenic effect on osteoblast-like MC3T3-E1 cells and that these cells produce an activin-binding protein, follistatin (Hashimoto, M., Shoda, A., Inoue, S., Yamada, R., Kondo, T., Sakurai, T., Ueno. N., and Muramatsu, M. (1992) J. Biol. Chem. 267, 4999-5004). Activin-A was also detected abundantly in bone matrix tissues and was found to act as an osteoclast differentiation factor. Here, we studied the expression of follistatin in bone tissues by in situ hybridization with a follistatin cRNA probe. Follistatin transcript was detected in the osteoblasts and a fraction of osteocyte population in the developing mouse mandible. Immunohistochemistry using anti-follistatin antibody supported this observation at the protein level. Follistatin mRNA was also detected in the callus of repairing bone after fracture. These findings suggest that activin and follistatin may play significant roles in the bone system in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7866921     DOI: 10.1007/bf00299321

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  17 in total

1.  Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin.

Authors:  M Hashimoto; A Shoda; S Inoue; R Yamada; T Kondo; T Sakurai; N Ueno; M Muramatsu
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

2.  Activin-binding protein from rat ovary is follistatin.

Authors:  T Nakamura; K Takio; Y Eto; H Shibai; K Titani; H Sugino
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

3.  Activin/EDF as an inhibitor of neural differentiation.

Authors:  M Hashimoto; S Kondo; T Sakurai; Y Etoh; H Shibai; M Muramatsu
Journal:  Biochem Biophys Res Commun       Date:  1990-11-30       Impact factor: 3.575

4.  Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation.

Authors:  Y Ogawa; D K Schmidt; R M Nathan; R M Armstrong; K L Miller; S J Sawamura; J M Ziman; K L Erickson; E R de Leon; D M Rosen
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

5.  Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin beta A chain.

Authors:  M Murata; Y Eto; H Shibai; M Sakai; M Muramatsu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  Modulation of growth of vascular smooth muscle cells by activin A.

Authors:  I Kojima; H Mogami; N Kawamura; H Yasuda; H Shibata
Journal:  Exp Cell Res       Date:  1993-05       Impact factor: 3.905

7.  Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

8.  Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.

Authors:  C Chenu; J Pfeilschifter; G R Mundy; G D Roodman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing.

Authors:  T Nakase; S Nomura; H Yoshikawa; J Hashimoto; S Hirota; Y Kitamura; S Oikawa; K Ono; K Takaoka
Journal:  J Bone Miner Res       Date:  1994-05       Impact factor: 6.741

10.  Novel regulators of bone formation: molecular clones and activities.

Authors:  J M Wozney; V Rosen; A J Celeste; L M Mitsock; M J Whitters; R W Kriz; R M Hewick; E A Wang
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more
  8 in total

1.  Serum follistatin in patients with prostate cancer metastatic to the bone.

Authors:  Francesca Maria Tumminello; Giuseppe Badalamenti; Fabio Fulfaro; Lorena Incorvaia; Marilena Crescimanno; Carla Flandina; Maria Vittoria Sepporta; Gaetano Leto
Journal:  Clin Exp Metastasis       Date:  2010-07-11       Impact factor: 5.150

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 3.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

4.  Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause.

Authors:  MaryFran R Sowers; Huiyong Zheng; Mary L Jannausch; Daniel McConnell; Bin Nan; Sioban Harlow; John F Randolph
Journal:  J Clin Endocrinol Metab       Date:  2010-03-09       Impact factor: 5.958

Review 5.  BMP signalling in skeletal development, disease and repair.

Authors:  Valerie S Salazar; Laura W Gamer; Vicki Rosen
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

Review 6.  Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.

Authors:  Kristy M Nicks; Daniel S Perrien; Nisreen S Akel; Larry J Suva; Dana Gaddy
Journal:  Mol Cell Endocrinol       Date:  2009-07-15       Impact factor: 4.102

7.  Bone Geometry Is Altered by Follistatin-Induced Muscle Growth in Young Adult Male Mice.

Authors:  Audrey S M Chan; Narelle E McGregor; Ingrid J Poulton; Justin P Hardee; Ellie H-J Cho; T John Martin; Paul Gregorevic; Natalie A Sims; Gordon S Lynch
Journal:  JBMR Plus       Date:  2021-03-03

Review 8.  Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Toshifumi Sugatani
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.